BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3141828)

  • 1. Effect of treatment with fluosol and mannitol during temporary middle cerebral artery occlusion in cats.
    Pereira BM; Weinstein PR; Rodriguez y Baena R
    Neurosurgery; 1988 Aug; 23(2):139-42. PubMed ID: 3141828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ; Ishikawa R; Hunter IG; Peerless MJ
    Stroke; 1981; 12(5):558-63. PubMed ID: 6795765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effect of fluosol DA and dextran 40 on regional cerebral blood flow, infarction size, and mortality in cats with temporary occlusion of the middle cerebral artery.
    Kolluri S; Heros RC; Hedley-Whyte ET; Vonsattel JP; Miller D; Zervas NT
    Surg Neurol; 1986 Jul; 26(1):3-8. PubMed ID: 2424107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R; Peerless SJ; Hunter IG
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia.
    Sutherland GR; Farrar JK; Peerless SJ
    Stroke; 1984; 15(5):829-35. PubMed ID: 6433517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Fluosol on oxygen availability, regional cerebral blood flow, and infarct size in a model of temporary focal cerebral ischemia.
    Kolluri S; Heros RC; Hedley-Whyte ET; Vonsattel JP; Miller D; Zervas NT
    Stroke; 1986; 17(5):976-80. PubMed ID: 3764970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cats.
    Weinstein PR; Anderson GG; Telles DA
    Stroke; 1986; 17(2):318-24. PubMed ID: 3961841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
    Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
    Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mild intraischemic hypothermia versus mannitol to reduce infarct size after temporary middle cerebral artery occlusion in rats.
    Karibe H; Zarow GJ; Weinstein PR
    J Neurosurg; 1995 Jul; 83(1):93-8. PubMed ID: 7782857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats.
    Weinstein PR; Anderson GG; Telles DA
    Neurosurgery; 1987 Apr; 20(4):518-24. PubMed ID: 3587541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of cerebral ischemia with Fluosol.
    Peerless SJ; Nakamura R; Rodriguez-Salazar A; Hunter IG
    Stroke; 1985; 16(1):38-43. PubMed ID: 3966263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mannitol on cerebral blood flow and microcirculation during experimental middle cerebral artery occlusion.
    Tanaka A; Tomonaga M
    Surg Neurol; 1987 Sep; 28(3):189-95. PubMed ID: 3114900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of opiate antagonists on middle cerebral artery occlusion infarct in the rat.
    Obana WG; Pitts LH; Nishimura MC
    J Neurosurg; 1988 Jul; 69(1):98-103. PubMed ID: 3132541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Fluosol-DA and hetastarch on local cerebral blood flow, cortical O2 availability and computerized EEG data during cerebral ischaemia.
    Tranmer BI; Iacobacci R; Feiler S
    Neurol Res; 1990 Mar; 12(1):17-22. PubMed ID: 1692110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs.
    Kolodgie FD; Dawson AK; Forman MB; Virmani R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 50(2):119-34. PubMed ID: 2868560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mannitol on focal cerebral ischemia evaluated by somatosensory-evoked potentials and magnetic resonance imaging.
    Kobayashi H; Ide H; Kabuto M; Handa Y; Kubota T; Ishii Y
    Surg Neurol; 1995 Jul; 44(1):55-61; discussion 61-2. PubMed ID: 7482256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of mannitol and perfluorochemicals on hemorrhagic infarction: an experimental study.
    Kagawa S; Koshu K; Yoshimoto T; Suzuki J
    Surg Neurol; 1982 Jan; 17(1):66-70. PubMed ID: 6803373
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of cerebral ischemia with Dextran-40 or Fluosol DA 20%.
    Kline RA; Negendank W; McCoy LE
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):979-83. PubMed ID: 1382645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suppression of infarctic changes with mannitol and fluorochemicals--an experimental study].
    Tanaka S; Seki H; Yoshimoto T; Suzuki J
    No To Shinkei; 1981 Nov; 33(11):1141-6. PubMed ID: 6800387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the extent of ischemic skeletal muscle necrosis by perfusion with oxygenated perfluorocarbon.
    Mohan C; Gennaro M; Marini C; Ascer E
    Am J Surg; 1992 Sep; 164(3):194-8. PubMed ID: 1329572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.